Carlstadt, NJ, March 13, 2006 – Pictorial Offset Corporation, the largest single-facility commercial printer in the United States, proudly announces that it has met the requirements and guidelines for current Good Manufacturing Practices (cGMP) for Pharmaceutical Inserts and Secondary Labeling established by the Federal Drug Administration. Pictorial currently follows the cGMP procedures when producing finished goods for pharmaceutical companies. These procedures include the Code of Federal Regulations from the Federal Drug Administration in Part 211, sections 1 through sections 150 – Current Good Manufacturing Practice for Finished Pharmaceuticals, including General Provisions, Organization and Personnel, Building and Facilities, Equipment, Control of Components and Drug Product Containers and Closures, Production and Process Controls, Packaging and Labeling Control and Holding and Distribution. “Pictorial has established separate facilities and production workflows for its Pharmaceutical clients, and segmented its offerings into two business units: PharmaWorks and PIWorks. We are pleased that our Pharma clients have asked us to expand our business into this area,” says Gary Samuels, Managing Partner of Pictorial Offset Corporation. “We value our customers and are always looking for ways to bring greater value to them by providing services that help manage their Pharmaceutical business in an efficient and ethical manner.”